Theravectys

About:

Theravectys develops a platform for the prevention and treatment of cancers and other infectious diseases and conditions.

Website: https://www.theravectys.com/

Twitter/X: theravectys

Top Investors: Bpifrance, Tethys BioScience, Guy PAILLAUD, Philippe ODDO, John PIETERS

Description:

Theravectys is a development-stage biotechnology company with a novel vaccine platform that can be applied to the treatment and prevention of a broad range of infectious diseases, cancers, and other diseases and conditions. Their first clinical studies will be in HIV/AIDS, using their lead product, a therapeutic vaccine, which has shown promising efficacy and safety in non-human primates.